英文名稱 Anti-ADAMTS13/FITC

中文名稱 FITC標(biāo)記的整合素樣金屬蛋白酶與凝血酶13型抗體

規(guī)格:100ul

說明書 100ul  

研究領(lǐng)域腫瘤  細胞生物  免疫學(xué)  信號轉(zhuǎn)導(dǎo)  細胞粘附分子  

抗體來源Rabbit

克隆類型Polyclonal

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse,

產(chǎn)品應(yīng)用IF=1:50-200  

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分子量145kDa

性    狀Lyophilized or Liquid

濃    度1mg/ml

免疫原KLH conjugated synthetic peptide derived from human ADAMTS13

亞    型IgG

純化方法affinity purified by Protein A

儲存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存條件Store at -20 °C for one year.

別　名　Cleaves the vWF multimers in plasma into smaller forms. Von Willebrand factor cleaving protease; A disintegrin and metalloproteinase with thrombospondin motifs 13; A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 13; A disintegrin like and metalloprotease with thrombospondin type 1 motif 13; ADAM metallopeptidase with thrombospondin type 1 motif 13; ADAM TS 13; ADAM TS13; ADAM-TS 13; ADAM-TS13; ADAMTS 13; ADAMTS-13; ADAMTS13; ADAMTS13 protein; ATS13_HUMAN; C9orf8; TTP; von Willebrand factor-cleaving protease; vWF cleaving protease; vWF CP; vWF-cleaving protease; vWF-CP; vWFCP.